Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study

Study Overview
=================
Brief Summary
-----------------
This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Official Title
-----------------
Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

Conditions
-----------------
Prostate Carcinoma

Intervention / Treatment
-----------------
* Other: Media Intervention
* Other: Media Intervention
* Other: Survey Administration


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Identify as a Black male Between the ages of 35 and 70 For virtual data collection, have access to the internet and Zoom (if joining study online) For virtual data collection, reside anywhere in the U.S. For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard Exclusion Criteria: Identify as a race or ethnicity that is not Black Identify as female Be younger than age 35 and older than age 70 Lack access to internet and Zoom (if joining study online)

Ages Eligible for Study
-----------------
Minimum Age: 35 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: MiCaP Research Digest Video Group<br>Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. | Other: Media Intervention<br>* Watch MiCaP Research Digest video<br>Other: Survey Administration<br>* Complete survey<br>|
| Active Comparator: Alternate Video Group<br>Participants watch an alternative video on study. Participants complete a survey throughout the trial. | Other: Media Intervention<br>* Watch alternate video<br>Other: Survey Administration<br>* Complete survey<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in perception of access to medical services and general health | Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response. | Baseline, 1 hour after video intervention | 
| Change in perception in participation with clinical trials about prostate cancer | Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response. | Baseline, 1 hour after video intervention | 
| Change in perception of familiarity with prostate cancer research | Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response. | Baseline, 1 hour after video intervention | 
| Change in perception of familiarity with a research study protocol | Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response. | Baseline, 1 hour after video intervention |